Published in
Lippincott, Williams & Wilkins, Anti-Cancer Drugs, 7(33), p. 682-685, 2022
DOI: 10.1097/cad.0000000000001291
Links
Tools
Poor response to selpercatinib plus crizotinib in a rearranged during transfection fusion-positive patient with acquired selpercatinib-resistant MNNG HOS transforming amplification: a case report
Journal article published in 2022 by
Zhaoting Meng,
Cuicui Zhang,
Ran Zuo,
Fuyi Zhu,
Yajie Wang,
Re Mi,
Meng Zhang,
Peng Chen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 